French Tech 120 - Promotion 2021
Le French Tech 120 est un programme d’accompagnement de l’État dédié aux 120 start-up françaises les plus performantes, en capacité de devenir leaders de rang international. Elles bénéficient pendant un an d’un accompagnement en lien avec leurs enjeux de développement en France et à l’international.
French Tech 120
2021

Amarisoft
4G and 5G from the lab to the field Amarisoft is a software company dedicated to LTE 4G (5G). Our world unique LTE software suite runs on standard x86 PC hardware (including PHY layer). Our LTE technology accelerates the process of building products like eNodeB, Core network or NB-IoT and … [voir plus]

BIOSerenity
Electrodiagnostic connecté et intégré en neurologie, cardiologie et sommeil. BioSerenity développe des solutions médicales connectées pour aider à diagnostiquer et à surveiller les patients atteints de maladies chroniques dans les domaines de la neurologie, des troubles du sommeil et de la cardiologie. Nous utilisons des capteurs physiologiques, une plateforme IoT, … [voir plus]

DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]

ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics an @Ipsen company designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. [voir plus]

Inotrem
Innovative personalized therapies targeting TREM-1 for life-threatening inflammatory syndromes such as septic shock Inotrem is a French biopharmaceutical company founded in 2013, with offices in Paris and a technology center in Nancy (France). Our mission is to improve public health by developing a new class of therapeutic solutions targeting the … [voir plus]

TISSIUM
Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, … [voir plus]

Shift Technology
The leading AI platform for insurance Shift delivers AI agents that transform insurers' most critical work. By combining deep industry expertise and unmatched data resources, Shift provides proven results that have earned the trust of hundreds of the world's leading insurers. Our insurance-grade AI is accurate, explainable, and secure—empowering human … [voir plus]

AFYREN
Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. … [voir plus]

Beacon Biosignals
Our mission is to improve human health by enabling rapid, targeted interventions through advanced brain analytics. Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances … [voir plus]

Dynacure
Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate … [voir plus]

ENYO Pharma
Développer des thérapies pour les maladies rénales chroniques ENYO Pharma développe des traitements thérapeutiques innovants basés sur des propriétés fibrolytiques et anti-inflammatoires pour les maladies associées à une insuffisance rénale. La société mène actuellement des essais de phase 2 avec son composé phare, le Vonafexor, dans le traitement des maladies … [voir plus]

KERANOVA
Advancing Ophthalmic Surgery Keranova is transforming cataract surgery with FemtoMatrix®, the first surgical platform using an ultra-fast multi-spot laser beam. This technology enables true photoemulsification®, replacing the traditional lens pre-cut approach. Clinical studies have demonstrated its safety and efficacy, with a 20% reduction in lens aspiration time and a significant … [voir plus]